Literature DB >> 2817111

ECT for Parkinson's disease.

R Abrams.   

Abstract

Entities:  

Mesh:

Year:  1989        PMID: 2817111     DOI: 10.1176/ajp.146.11.1391

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

1.  MK-801 prevents the enhanced behavioural response to apomorphine elicited by repeated electroconvulsive treatment in mice.

Authors:  G G Nomikos; A A Mathé; J M Mathé; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Psychiatry.

Authors:  K Granville-Grossman
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

3.  Cell implantation in Parkinson's disease.

Authors:  P Madeley; J L Boyd; C A Biggins; R H Mindham; E G Spokes
Journal:  BMJ       Date:  1990-09-15

Review 4.  Guide to anaesthetic selection for electroconvulsive therapy.

Authors:  Klaus J Wagner; Oliver Möllenberg; Michael Rentrop; Christian Werner; Eberhard F Kochs
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in the rat striatum.

Authors:  A P Zis; G G Nomikos; G Damsma; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.